|
1
|
Hirschfeld M, Kirschning CJ, Schwandner R,
Wesche H, Weis JH, Wooten RM and Weis JJ: Cutting edge:
Inflammatory signaling by Borrelia burgdorferi lipoproteins is
mediated by toll-like receptor 2. J Immunol. 163:2382–2386.
1999.PubMed/NCBI
|
|
2
|
Means TK, Wang S, Lien E, Yoshimura A,
Golenbock DT and Fenton MJ: Human toll-like receptors mediate
cellular activation by Mycobacterium tuberculosis. J Immunol.
163:3920–3927. 1999.PubMed/NCBI
|
|
3
|
Schwandner R, Dziarski R, Wesche H, Rothe
M and Kirschning CJ: Peptidoglycan- and lipoteichoic acid-induced
cell activation is mediated by toll-like receptor 2. J Biol Chem.
274:17406–17409. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takeuchi O, Hoshino K, Kawai T, Sanjo H,
Takada H, Ogawa T, Takeda K and Akira S: Differential roles of TLR2
and TLR4 in recognition of gram-negative and gram-positive
bacterial cell wall components. Immunity. 11:443–451. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hua F, Ma J, Ha T, Kelley JL, Kao RL,
Schweitzer JB, Kalbfleisch JH, Williams DL and Li C: Differential
roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion
injury in mice. Brain Res. 1262:100–108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ingalls RR, Lien E and Golenbock DT:
Differential roles of TLR2 and TLR4 in the host response to
Gram-negative bacteria: Lessons from a lipopolysaccharide-deficient
mutant of Neisseria meningitidis. J Endotoxin Res. 6:411–415. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Underhill DM and Gantner B: Integration of
Toll-like receptor and phagocytic signaling for tailored immunity.
Microbes Infect. 6:1368–1373. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Underhill DM, Ozinsky A, Smith KD and
Aderem A: Toll-like receptor-2 mediates mycobacteria-induced
proinflammatory signaling in macrophages. Proc Natl Acad Sci USA.
96:14459–14463. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Henrickson KJ, Hoover S, Kehl KS and Hua
W: National disease burden of respiratory viruses detected in
children by polymerase chain reaction. Pediatr Infect Dis J. 23 1
Suppl:S11–S18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Black CP: Systematic review of the biology
and medical management of respiratory syncytial virus infection.
Respir Care. 48:209–233. 2003.PubMed/NCBI
|
|
11
|
Berger TM, Aebi C, Duppenthaler A and
Stocker M: Swiss Pediatric Surveillance Unit: Prospective
population-based study of RSV-related intermediate care and
intensive care unit admissions in Switzerland over a 4-year period
(2001–2005). Infection. 37:109–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mansbach JM, Clark S, Christopher NC,
LoVecchio F, Kunz S, Acholonu U and Camargo CA Jr: Prospective
multicenter study of bronchiolitis: Predicting safe discharges from
the emergency department. Pediatrics. 121:680–688. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salem O, Erdem N, Jung J, Münstermann E,
Wörner A, Wilhelm H, Wiemann S and Körner C: The highly expressed
5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive
effects of miR-140 by reducing breast cancer proliferation and
migration. BMC Genomics. 17:5662016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zou J and Xu Y: MicroRNA-140 inhibits cell
proliferation in gastric cancer cell line HGC-27 by suppressing
SOX4. Med Sci Monit. 22:2243–2252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bakre A, Mitchell P, Coleman JK, Jones LP,
Saavedra G, Teng M, Tompkins SM and Tripp RA: Respiratory syncytial
virus modifies microRNAs regulating host genes that affect virus
replication. J Gen Virol. 93:2346–2356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Othumpangat S, Walton C and Piedimonte G:
MicroRNA-221 modulates RSV replication in human bronchial
epithelium by targeting NGF expression. PLoS One. 7:e300302012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu J, Zhang W, Tang H, Qian H, Yang J, Zhu
Z, Ren P and Lu B: Septin 2 accelerates the progression of biliary
tract cancer and is negatively regulated by mir-140-5p. Gene.
589:20–26. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Templeton KE, Scheltinga SA, Beersma MF,
Kroes AC and Claas EC: Rapid and sensitive method using multiplex
real-time PCR for diagnosis of infections by influenza a and
influenza B viruses, respiratory syncytial virus, and parainfluenza
viruses 1, 2, 3, and 4. J Clin Microbiol. 42:1564–1569. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mi QS, Xu YP, Wang H, Qi RQ, Dong Z and
Zhou L: Deletion of microRNA miR-223 increases Langerhans cell
cross-presentation. Int J Biochem Cell Biol. 45:395–400. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thornburg NJ, Hayward SL and Crowe JE Jr:
Respiratory syncytial virus regulates human microRNAs by using
mechanisms involving beta interferon and NF-κB. MBio. 3:pii:
e00220. 122012. View Article : Google Scholar
|
|
22
|
Schröder NW and Arditi M: The role of
innate immunity in the pathogenesis of asthma: Evidence for the
involvement of toll-like receptor signaling. J Endotoxin Res.
13:305–312. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abe T, Hemmi H, Miyamoto H, Moriishi K,
Tamura S, Takaku H, Akira S and Matsuura Y: Involvement of the
toll-like receptor 9 signaling pathway in the induction of innate
immunity by baculovirus. J Virol. 79:2847–2858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haynes LM, Moore DD, Kurt-Jones EA,
Finberg RW, Anderson LJ and Tripp RA: Involvement of toll-like
receptor 4 in innate immunity to respiratory syncytial virus. J
Virol. 75:10730–10737. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Randall RE and Goodbourn S: Interferons
and viruses: An interplay between induction, signalling, antiviral
responses and virus countermeasures. J Gen Virol. 89:1–47. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Durbin RK, Kotenko SV and Durbin JE:
Interferon induction and function at the mucosal surface. Immunol
Rev. 255:25–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
González-Navajas JM, Lee J, David M and
Raz E: Immunomodulatory functions of type I interferons. Nat Rev
Immunol. 12:125–135. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kumagai Y, Takeuchi O, Kato H, Kumar H,
Matsui K, Morii E, Aozasa K, Kawai T and Akira S: Alveolar
macrophages are the primary interferon-alpha producer in pulmonary
infection with RNA viruses. Immunity. 27:240–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim D, Martinez-Sobrido L, Choi C, Petroff
N, García-Sastre A, Niewiesk S and Carsillo T: Induction of type I
interferon secretion through recombinant Newcastle disease virus
expressing measles virus hemagglutinin stimulates antibody
secretion in the presence of maternal antibodies. J Virol.
85:200–207. 2011. View Article : Google Scholar : PubMed/NCBI
|
